Panchsheel Organics Ltd
Incorporated in 1990, Panchsheel Organics Ltd is a manufacturer of Bulk Drug and Intermediate[1]
- Market Cap ₹ 138 Cr.
- Current Price ₹ 105
- High / Low ₹ 184 / 100
- Stock P/E 11.2
- Book Value ₹ 105
- Dividend Yield 3.06 %
- ROCE 13.6 %
- ROE 10.6 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 1.00 times its book value
- Company has delivered good profit growth of 21.1% CAGR over last 5 years
Cons
- Company has a low return on equity of 13.5% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 39 | 36 | 40 | 40 | 42 | 48 | 50 | 49 | 69 | 103 | 105 | 107 | 104 | |
| 35 | 31 | 34 | 33 | 35 | 41 | 42 | 41 | 56 | 83 | 86 | 90 | 88 | |
| Operating Profit | 4 | 5 | 6 | 7 | 7 | 7 | 9 | 9 | 13 | 20 | 19 | 18 | 16 |
| OPM % | 11% | 13% | 14% | 17% | 16% | 14% | 17% | 18% | 19% | 19% | 18% | 16% | 15% |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 3 | 2 | |
| Interest | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Profit before tax | 3 | 3 | 4 | 5 | 5 | 6 | 7 | 7 | 11 | 19 | 19 | 18 | 16 |
| Tax % | 35% | 32% | 27% | 36% | 29% | 29% | 28% | 31% | 27% | 26% | 27% | 24% | |
| 2 | 2 | 3 | 3 | 4 | 4 | 5 | 5 | 8 | 14 | 14 | 14 | 12 | |
| EPS in Rs | 1.76 | 1.90 | 3.04 | 3.21 | 3.67 | 4.04 | 5.29 | 5.01 | 8.33 | 11.94 | 10.71 | 10.47 | 9.34 |
| Dividend Payout % | 14% | 13% | 17% | 16% | 14% | 12% | 0% | 20% | 18% | 7% | 7% | 8% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 16% |
| 3 Years: | 16% |
| TTM: | -6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 21% |
| 3 Years: | 18% |
| TTM: | -10% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 20% |
| 3 Years: | -23% |
| 1 Year: | -31% |
| Return on Equity | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 14% |
| 3 Years: | 13% |
| Last Year: | 11% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 10 | 12 | 13 | 13 | 13 |
| Reserves | 12 | 13 | 16 | 19 | 22 | 25 | 30 | 35 | 37 | 84 | 112 | 121 | 125 |
| 5 | 7 | 5 | 7 | 6 | 5 | 4 | 4 | 4 | 6 | 6 | 5 | 4 | |
| 12 | 8 | 11 | 9 | 12 | 9 | 12 | 14 | 22 | 21 | 28 | 24 | 29 | |
| Total Liabilities | 35 | 33 | 37 | 39 | 44 | 44 | 52 | 58 | 74 | 123 | 159 | 163 | 171 |
| 8 | 7 | 7 | 8 | 7 | 7 | 6 | 7 | 7 | 8 | 14 | 18 | 19 | |
| CWIP | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 4 | 6 | 15 | 17 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 |
| 28 | 26 | 28 | 30 | 36 | 36 | 44 | 49 | 65 | 111 | 137 | 131 | 135 | |
| Total Assets | 35 | 33 | 37 | 39 | 44 | 44 | 52 | 58 | 74 | 123 | 159 | 163 | 171 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 | 1 | 3 | 1 | 3 | 2 | 5 | 5 | -2 | 0 | 10 | 4 | |
| -1 | -1 | -2 | -2 | -1 | -1 | -2 | -1 | -0 | -34 | -7 | -16 | |
| -2 | 0 | -1 | 1 | -2 | -2 | -1 | -2 | -1 | 36 | 16 | -5 | |
| Net Cash Flow | 0 | 0 | -1 | 0 | -0 | 0 | 1 | 3 | -2 | 1 | 18 | -18 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 130 | 142 | 134 | 138 | 170 | 137 | 164 | 140 | 172 | 137 | 137 | 119 |
| Inventory Days | 124 | 154 | 155 | 185 | 185 | 164 | 186 | 246 | 237 | 181 | 211 | 246 |
| Days Payable | 108 | 80 | 109 | 83 | 124 | 73 | 111 | 152 | 158 | 89 | 114 | 88 |
| Cash Conversion Cycle | 146 | 216 | 181 | 240 | 231 | 229 | 239 | 235 | 251 | 230 | 234 | 276 |
| Working Capital Days | 104 | 136 | 138 | 137 | 150 | 155 | 170 | 167 | 192 | 173 | 178 | 204 |
| ROCE % | 15% | 14% | 19% | 20% | 18% | 18% | 20% | 19% | 25% | 26% | 17% | 14% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Calculated Production Volume Kg |
|
|||||||||
| Electricity Consumption per unit of Production Units/Kg |
||||||||||
| Number of Permanent Employees Number |
||||||||||
| Gas / Fuel Consumption per unit of Production Units/Kg |
||||||||||
| Manufacturing Blocks Number |
||||||||||
| Export Countries Number |
||||||||||
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
16 Feb - Newspaper publication for unaudited financial result for the quarter and nine months ended December 31, 2025
- Board Fixes Record Date For The Purpose Of Entitlements To The Shareholders Over Interim Dividend Declared For The Quarter And Nine Months Ended December 31, 2025 In Its Meeting Held On 14Th February, 2026. 14 Feb
- Corporate Action-Board approves Dividend 14 Feb
-
Unaudited Financial Result For The Quarter And Nine Months Ended December 31, 2025
14 Feb - Declared interim dividend Rs0.80/share; Q3 and nine-month unaudited results; dividend payable by 13 Mar 2026, record date 20 Feb 2026.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, 14Th February, 2026
14 Feb - Unaudited Q3/9M results; interim dividend Rs0.80/share; record date Feb 20, 2026; pay by Mar 13, 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
POL is a part of Turakhia Bros group. It is a WHO Compliant, ISO and GMP certified manufacturer and exporter of a range of APIs, Intermediates, Nutraceutical, Vitamins Hormones, Steroids, Finished Formulations (Human & Veterinary), Agri Biotech range (Bio Fertilizers, Bio Stimulants,Growth Promoters), Aqua Culture, Dehydrated Culture Media